logo

For the Inventor, By the Inventor

Berlin, Germany

Precision for Medicine Gmbh

Calculating rank
USPTO Granted Patents = 16



Forward Citations = 1

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Sven Olek (15 out of 28 patents)

silverMedal Udo Baron (3 out of 5 patents)

bronzeMedal Kati Bourquain (2 out of 2 patents)

4.  Ulrich Hoffmüller (1 out of 2 patents)

5.  Ivana Türbachova (1 out of 3 patents)

6.  Janika Josephin Schulze (1 out of 1 patent)

7.  Sven Olek (1 out of 1 patent)

8.  Rosa Bacchetta (1 out of 5 patents)

9.  Josephin Held (1 out of 1 patent)

10.  Vishal Gupta (0 patent)

11.  David K Hasegawa (0 patent)

12.  Ronald Pethig (0 patent)

13.  Anoop Menachery (0 patent)


16 patents:

1. 12729403 - MYH11/NDE1 REGION AS EPIGENETIC MARKER FOR THE IDENTIFICATION OF ENDOTHELIAL PROGENITOR CELLS (EPCS) (2026-09-08),
2. 12674205 - CBX6 AS EPIGENETIC MARKER FOR THE IDENTIFICATION OF IMMUNE CELLS, IN PARTICULAR MEMORY B CELLS (2026-07-07),
3. 12305237 - CXCR3 as epigenetic marker for the identification of inflammatory immune cells, in particular CD8+ memory t cells (2025-05-20),
4. 12286675 - Epigenetic markers for the identification of blood sub-cells of type 1 (2025-04-29),
5. 12247258 - Epigenetic method to detect and distinguish IPEX and IPEX-like syndromes, in particular in newborns (2025-03-11),
6. 12006546 - Method for epigenetic immune cell detection and counting in human blood samples (2024-06-11),
7. 11976327 - ERGIC1 as epigenetic marker for the identification of immune cells, in particular monocytic myeloid-derived suppressor cells (mMDSCs) (2024-05-07),
8. 11788141 - MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells (2023-10-17),
9. 11761041 - PARK2 as epigenetic marker for the identification of immune cells, in particular monocytes (2023-09-19),
10. 11753683 - MCC as epigenetic marker for the identification of immune cells, in particular basophil granulocytes (2023-09-12),
11. 11725243 - Epigenetic method for the identification of follicular T-helper-(TFH-) cells (2023-08-15),
12. 11680294 - Amplicon region as epigenetic marker for the identification of non-classical monocytes (2023-06-20),
13. 11667973 - Endosialin (CD248) as epigenetic marker for the identification of immune cells, in particular naïve CD8+ t-cells (2023-06-06),
14. 11643687 - LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells (2023-05-09),
15. 11597975 - PDCD1 as epigenetic marker for the identification of immune cells, in particular PD1+ cells (2023-03-07),
Company Overview
Precision for Medicine GmbH, based in Berlin, specializes in providing comprehensive services and solutions tailored for the life sciences sector. The company focuses on enhancing clinical development processes through innovative technologies and expertise in areas such as biometrics, regulatory affairs, and patient engagement. By leveraging advanced analytics and a deep understanding of the healthcare landscape, Precision for Medicine aims to streamline drug development and improve patient outcomes across various therapeutic areas.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

16 Patents

#62 in D-1000 Berlin

#2,629 in Germany

#37,914 in the World

Berlin, DE
Berlin, Germany

Precision for Medicine Gmbh

Forward Citations = 1

9 inventors:

goldMedal Sven Olek (15 out of 28 patents)

silverMedal Udo Baron (3 out of 5 patents)

bronzeMedal Kati Bourquain (2 out of 2 patents)

4.  Ulrich Hoffmüller (1 out of 2 patents)

5.  Ivana Türbachova (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Precision for Medicine Gmbh. Retrieved from https://idiyas.com/company/precision-for-medicine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…